Status:

RECRUITING

A Review of the Management and Outcomes of Children With SMA in the West Midlands During 2017-2022

Lead Sponsor:

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

Collaborating Sponsors:

University Hospital Birmingham NHS Foundation Trust

Conditions:

Spinal Muscular Atrophy

Eligibility:

All Genders

Up to 16 years

Brief Summary

Spinal Muscular Atrophy (SMA) is a rare neuromuscular condition, characterised by loss of motor neurons as a result of a mutation in the survival motor neuron gene. This results in muscle wasting and ...

Detailed Description

Spinal muscular atrophy (SMA) is a rare neuromuscular disorder characterized by degeneration of alpha motor neurons in the spinal cord resulting in progressive muscle wasting, weakness, and paralysis,...

Eligibility Criteria

Inclusion

  • Patient aged \<16 years old as of 1st July 2017. (16 years old is the age in which patients typically start their transition process to adulthood - retrospective data collection will stop at the date in which the patient turned 16 years old, if this is before 30th June 2022).
  • OR patient was born between 1st July 2017 - 30th June 2022.
  • Genetically confirmed 5q SMA.
  • Patients must have been under the care of the named Key Collaborative Site and Neuromuscular Service for their SMA anytime during 1st July 2017- 30th June 2022 and must have had at least two clinical reviews during this time.
  • Deceased patients can be reviewed, as long as they met the eligibility criteria before their date of death.

Exclusion

  • Aged ≥16 years as of 1st July 2017.
  • Genetically confirmed as having non-5q SMA or have no genetic confirmation of their diagnosis.
  • Patient was not under the care of the named Key Collaborative Site and Neuromuscular Service for their SMA specialist care anytime during 1st July 2017 - 30th June 2022.

Key Trial Info

Start Date :

December 6 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05994950

Start Date

December 6 2023

End Date

December 31 2024

Last Update

April 12 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Birmingham Heartlands Hospital

Birmingham, Shropshire, United Kingdom, B9 5SS

2

The Robert Jones and Agnes Hunt Orthopaedic Hospital

Oswestry, Shropshire, United Kingdom, SY10 7AG

A Review of the Management and Outcomes of Children With SMA in the West Midlands During 2017-2022 | DecenTrialz